The effect of levofloxacin for patients with non-muscle invasive bladder cancer treated by intravesical Bacillus Calmette-Guerin: Results of a randomized, prospective, multicenter study
Main Authors: | K. Numakura, M. Kobayashi, T. Ishida, K. Okane, K. Suzuki, N. Shimoda, T. Kumazawa, T. Suzuki, R. Sasaki, H. Fukuda, T. Nara, S. Kanda, M. Huang, M. Saito, S. Narita, T. Inoue, N. Tsuchiya, T. Habuchi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-07-01
|
Series: | European Urology Open Science |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666168320335370 |
Similar Items
-
Safety profiles of intravesical Bacillus Calmette-Guerin in bladder cancer
by: Yun Peng, et al.
Published: (2024-12-01) -
Granulomatous Prostatitis Associated with Intravesical Bacillus Calmette Guerin Therapy
by: Elif Gündoğdu
Published: (2024-02-01) -
Intravesical Bacillus Calmette-Guerin for Treatment of Refractory Interstitial Cystitis
by: Saeed Arasteh, et al.
Published: (2007-02-01) -
Penile tuberculosis following intravesical Bacille Calmette-Guérin immunotherapy
by: Anadi Roy Chowdhury, et al.
Published: (2013-01-01) -
Interstitial pneumonitis secondary to intravesical bacillus calmette-guerin for carcinoma in-situ of the bladder
by: Eric K. Diner, et al.
Published: (2004-10-01)